Can I get it?
Yes, if a doctor decides it is right for you. Topical minoxidil is authorised in the EU and can be prescribed after a medical review.
Topical minoxidil · AlmeríaPrescription only
Online medical consultation for Topical minoxidil in Almería.
An EU-licensed doctor reviews your case and, if eligible, issues an electronic prescription valid in any pharmacy in Spain. Consultation €15/month, refunded if the doctor decides it is not safe to prescribe.
- Topical or oral, depending on your case
- Stimulates the follicle's growth phase
- Combines well with finasteride or dutasteride
€15/month (billed €45 every 3 months)Full refund if a review is not approved
Medication, if prescribed, is dispensed and paid for separately at a pharmacy.
IN PLAIN TERMS
What Topical minoxidil is, and how to get treatment
Minoxidil comes in two very different forms, and the difference matters. The liquid or foam you rub into your scalp is a properly authorised medicine for male pattern hair loss in EU countries, sold both on prescription and over the counter, and it is the form the hair-loss evidence above is based on. Minoxidil also exists as a tablet, but in the EU those tablets are only licensed as a blood-pressure medicine; taking low-dose minoxidil tablets for hair is off-label, which means a doctor is prescribing it outside its licensed use. The commonest problems are an itchy or flaky scalp with the topical form, and unwanted hair growing in places you did not want it, which happened to about 15 in 100 people in a large study of the off-label tablets.
Topical minoxidil has been authorised for use in the EU since 1 May 1988, so a licensed doctor can prescribe it when it is clinically appropriate for you.
What can I take instead?
Our doctors review every Hair growth option and recommend what fits your history and goals.
See all Hair growth optionsWhat do the studies show?
Every trial behind Topical minoxidil is listed below with how many people took part and whether the results are peer-reviewed or a company announcement.
Jump to the studiesLocal consultation facts
Can I get Topical minoxidil in Almería?
Yes. People in Almería, Spain, can request an online doctor consultation about Topical minoxidil with Hi-Doctor. A licensed EU doctor reviews the case and issues a prescription only when clinically appropriate. If approved, the electronic prescription arrives as a QR code that can be dispensed directly in Spain.
Availability
Topical minoxidil is available to residents of Spain through the online consultation. A prescription follows only if the doctor approves it.
- Country
- Spain
- Language of service
- Spanish and English
- Prescription turnaround
- Within 24 hours, only if the doctor approves
- Honoured locally
- QR electronic prescription, dispensed directly in Spain
How the EU prescription works where you are: In Spain, an approved prescription arrives electronically with a QR code for direct dispensing.
VERIFIED EVIDENCE
Topical minoxidil: evidence and regulatory guide.
WHAT IT IS
How it works
Applied to the scalp it widens small blood vessels and appears to keep hair follicles in their growing phase for longer, although exactly how it acts on hair is still not fully understood.
- ATP-sensitive potassium channels
DEVELOPMENT STAGE
EU-authorised medicine
Trial register2 registered trials
Every NCT identifier links to its ClinicalTrials.gov record. A readout is not the same as peer-reviewed publication.
| TRIAL / NCT | POPULATION | PARTICIPANTS | STATUS | READOUT / COMPLETION |
|---|---|---|---|---|
| 5% vs 2% topical minoxidil solution vs placebo in men (48-week, double-blind, multicentre) | Men aged 18-49 with vertex androgenetic alopecia | 393 | Read out | 2002-09-01 |
| Oral minoxidil 5 mg vs topical minoxidil 5% (double-blind randomised clinical trial, Brazil; registry RBR-252w9r) | Men aged 18-55 with androgenetic alopecia; 68 of 90 randomised completed | 90 | Read out | 2024-04-10 |
What the studies reported
Results are grouped by source and evidence grade so journal data and manufacturer announcements cannot be confused.
Peer-reviewed
Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377-385. doi:10.1067/mjd.2002.124088 (PMID 12196747)| DOSE OR GROUP | MEAN WEIGHT CHANGE | WEEKS |
|---|---|---|
| 5% topical solution, twice daily | +18.6 non-vellus hairs/cm2 from baseline | 48 |
| 2% topical solution, twice daily | +12.7 non-vellus hairs/cm2 from baseline | 48 |
| placebo (vehicle), twice daily | +3.9 non-vellus hairs/cm2 from baseline | 48 |
The trial ran for 48 weeks in men aged 18-49 with vertex-pattern loss, so it does not establish results beyond one year or in other patterns of hair loss.
Sources
Last reviewed 2026-07-27
- AEMPS CIMA - Regaxidil 20 mg/ml solucion cutanea, ficha tecnica (Spain, registration 57597, authorised 1 May 1988) - indicated for moderate androgenetic alopecia
- AEMPS CIMA - Regaine 50 mg/g espuma cutanea, ficha tecnica (Spain, registration 76483) - indicated for androgenetic alopecia in adult men
- AEMPS CIMA - Loniten 10 mg comprimidos, ficha tecnica (Spain, registration 55636) - oral minoxidil, indicated for severe hypertension only
- AEMPS CIMA - Minogal 2,5/5/10 mg comprimidos EFG, ficha tecnica (Spain, registration 91045-91047, authorised 2026) - oral minoxidil, indicated for severe resistant hypertension only
- Olsen et al., J Am Acad Dermatol 2002;47(3):377-385 (PMID 12196747)
- Penha MA, Miot HA, Kasprzak M, Muller Ramos P. Oral minoxidil vs topical minoxidil for male androgenetic alopecia: a randomized clinical trial. JAMA Dermatol. 2024;160(6):600-605 (PMID 38598226)
- Vano-Galvan S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651 (PMID 33639244)
- Rodrigues Dias F, Yong SS, FitzGerald H, Sinclair RD, Bhoyrul B. Expanding the therapeutic landscape of minoxidil for androgenetic alopecia. Front Pharmacol. 2026;16:1718208 - reproduces the Olsen 2002 hair-count figures and states oral minoxidil is not formally approved for AGA
NAMED SAFETY SIGNALS
What has been reported with Topical minoxidil.
Scalp reactions with the topical product
Itching, dermatitis, acneiform dermatitis and rash are listed as common in the EU product information for topical minoxidil. Application-site reactions can occasionally be more severe and include peeling, blistering, bleeding or ulceration.
Unwanted hair growth away from the scalp (hypertrichosis)
Listed as common in the EU product information for topical minoxidil, including facial hair growth in women.
Headache and breathlessness with the topical product
Headache and dyspnoea are listed as common; dizziness, nausea and peripheral oedema as uncommon; palpitations, tachycardia and chest pain as rare; low blood pressure and allergic reactions including angioedema at a frequency that is not known.
Temporary increased shedding with the topical product
Temporary hair loss is listed in the EU product information at a frequency that is not known.
Off-label low-dose oral minoxidil - side effects in a randomised comparison
In a 24-week randomised trial of oral minoxidil 5 mg vs topical minoxidil 5% (n=45 per arm), hypertrichosis occurred in 22/45 (49%) on the oral drug vs 11/45 (25%) on topical (P=.02) and headache in 6/45 (14%) vs 1/45 (2%) (P=.046); scalp eczema was more frequent with topical, 7/45 (16%) vs 1/45 (2%).
Off-label low-dose oral minoxidil - side effects in a large observational series
In a retrospective multicentre study of 1,404 patients treated for at least 3 months, the most frequent adverse effect was hypertrichosis (15.1%, causing withdrawal in 0.5%). Systemic effects were lightheadedness 1.7%, fluid retention 1.3%, tachycardia 0.9%, headache 0.4%, periorbital oedema 0.3% and insomnia 0.2%, leading to discontinuation in 1.2% of patients.
What oral minoxidil tablets are actually licensed for in the EU
EU-authorised minoxidil tablets are indicated only for severe resistant high blood pressure and their product information states they must never be used alone or as initial therapy, always alongside a beta-blocker and a diuretic. None of that licensed dosing framework applies to the low doses used off-label for hair loss.
Form5% topical solution or low-dose tablet
FrequencyDaily routine
ResultsFirst changes at months 2–4
StatusPrescription only
About
What is Topical minoxidil?
Active ingredient: Minoxidil · Dosages: 5% topical · 2.5–5 mg oral
Minoxidil prolongs the anagen (growth) phase of the hair follicle and increases hair diameter. Topical is the standard in mild-to-moderate androgenetic alopecia; low-dose oral — off-label, under medical supervision — is an alternative when adherence to topical is poor or the response is insufficient.
It's frequently combined with a 5-alpha-reductase inhibitor: minoxidil stimulates the follicle while finasteride or dutasteride blocks the hormonal cause. The doctor decides the form and the combination based on your history and pattern of loss.
How it works in the body
Minoxidil extends the follicle's growth phase and increases hair diameter, improving density where follicles are still active. Each form — topical or low-dose oral — has its own side-effect profile, which the doctor reviews with you.
How it helps
How it supports regrowth.
Stimulates the follicle
Prolongs the growth phase and thickens the hair shaft.
Two formats
Topical solution as the standard; low-dose oral when topical doesn't fit.
Pairs well
Often combined with finasteride or dutasteride to also block the hormonal cause.
What to expect
How to use it.
Topical is applied twice daily to thinning areas; the oral form is a once-daily low-dose tablet. Your doctor prescribes the form most appropriate for you.
- Weeks 1–8 · Build the daily routine
- Months 2–4 · Early density changes
- Months 4–6 · Response assessed by your doctor
- Ongoing · Keep the routine to keep the results
Forms your doctor can prescribe
- Topical solution5% (50 mg/ml) — twice daily
- Oral (low dose)2.5 – 5 mg / day
Your schedule is personal
These are typical steps only. Your doctor adjusts the plan to how you respond and tolerate it — and you can message them at any point.
Safety first
Safety, in full.
Topical minoxidil is an effective medicine — and like any medicine it carries risks. Your doctor screens for all of this before prescribing. Here's the honest picture, not just reassurance.
Adults with androgenetic alopecia or telogen effluvium.
- Topical solution / foam: 1 mL applied to a dry scalp twice daily; do not rinse for at least 4 hours.
- Initial shedding around weeks 2–8 is common — this is the old hair making room for the new growth, not a worsening.
- Visible response usually appears at 3–6 months; stopping reverses the gains.
- Low-dose oral minoxidil is an off-label option for selected patients; only when prescribed by your doctor.
Who should not use it
- Pregnancy or breastfeeding.
- Children under 18.
- Known hypersensitivity to minoxidil or propylene glycol (for the solution).
- Active scalp disease — broken skin, severe eczema or psoriasis on the scalp until treated.
- Significant cardiovascular disease or pheochromocytoma — discuss with the doctor before any oral use.
When to seek urgent care
For severe, sudden or unexpected symptoms, call your local emergency number or go to the nearest emergency department. Then let your doctor know through your account chat.
PRICING
Two clear ways to continue your care.
€25/month for weight loss or €15/month (billed €45 every 3 months) for hair growth. €35 one-off is available for sexual health.
ONGOING PLAN
Ongoing treatment plan
Hair growth
€15/month
billed €45 every 3 months
For ongoing treatment and doctor-reviewed renewals.
Available for weight-loss and hair-growth treatments.
Start consultationWHAT'S INCLUDED
- First consultation included
- Renewals reviewed by your doctor
- Ongoing care with your doctor
- Priority review
- Cancel anytime
Full refund if a review is not approved If a review is not approved, we refund that period's €45 fee and cancel the plan.
Note: The medication, if the doctor prescribes it, is paid separately at the pharmacy at the price it sets. Hi-Doctor does not sell medications.
HOW THE DOCTOR DECIDES
A licensed doctor reviews your case, not an algorithm
An EU-licensed doctor reads your questionnaire and answers within 24 hours.
If the doctor decides it is not safe to prescribe, the consultation fee is refunded in full.
Follow-up happens in the private chat inside your account, under GDPR. No WhatsApp, no SMS.
OTHER HAIR GROWTH TREATMENTS
Explore related treatments.
Find out if it's right for you
See if Topical minoxidil is appropriate for you.
Answer a few questions and a licensed EU doctor reviews your case within 24 hours. Refunded in full if it's not right for you.
ALSO AVAILABLE IN
The Topical minoxidil consultation works the same way across the EU.
SpainESFranceFRGermanyDEItalyITPortugalPTNetherlandsNLBelgiumBEIrelandIEPolandPLCzechiaCZSlovakiaSKHungaryHURomaniaROBulgariaBGGreeceGRCyprusCYCroatiaHRSloveniaSIAustriaATDenmarkDKSwedenSEFinlandFIEstoniaEELatviaLVLithuaniaLTLuxembourgLUMaltaMT